160 related articles for article (PubMed ID: 29446085)
41. Strong association of interleukin-6 -174G/C promoter single nucleotide polymorphism with a decreased risk of colorectal cancer in ethnic Kashmiri population: A case control study.
Banday MZ; Balkhi HM; Sameer AS; Chowdri NA; Haq E
Tumour Biol; 2017 Mar; 39(3):1010428317695940. PubMed ID: 28349833
[TBL] [Abstract][Full Text] [Related]
42. Presence of Twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors.
Celesti G; Di Caro G; Bianchi P; Grizzi F; Basso G; Marchesi F; Doni A; Marra G; Roncalli M; Mantovani A; Malesci A; Laghi L
Gastroenterology; 2013 Sep; 145(3):647-57.e15. PubMed ID: 23684708
[TBL] [Abstract][Full Text] [Related]
43. KLF8 promotes tumorigenesis, invasion and metastasis of colorectal cancer cells by transcriptional activation of FHL2.
Yan Q; Zhang W; Wu Y; Wu M; Zhang M; Shi X; Zhao J; Nan Q; Chen Y; Wang L; Cheng T; Li J; Bai Y; Liu S; Wang J
Oncotarget; 2015 Sep; 6(28):25402-17. PubMed ID: 26320172
[TBL] [Abstract][Full Text] [Related]
44. Association of single nucleotide polymorphisms in the coding region of Bcl-2 with the occurrence and prognosis of colorectal cancer: A case-control study.
Huang B; Liu X; Sun C; Wang L; Yang L
Cancer Biomark; 2017; 18(4):433-439. PubMed ID: 28106544
[TBL] [Abstract][Full Text] [Related]
45. Lipocalin2 suppresses metastasis of colorectal cancer by attenuating NF-κB-dependent activation of snail and epithelial mesenchymal transition.
Feng M; Feng J; Chen W; Wang W; Wu X; Zhang J; Xu F; Lai M
Mol Cancer; 2016 Dec; 15(1):77. PubMed ID: 27912767
[TBL] [Abstract][Full Text] [Related]
46. SNPs in microRNA-binding sites in the ITGB1 and ITGB3 3'-UTR increase colorectal cancer risk.
Ye P; Li Z; Jiang H; Liu T
Cell Biochem Biophys; 2014 Sep; 70(1):601-7. PubMed ID: 24777809
[TBL] [Abstract][Full Text] [Related]
47. The rs6983267 SNP is associated with MYC transcription efficiency, which promotes progression and worsens prognosis of colorectal cancer.
Takatsuno Y; Mimori K; Yamamoto K; Sato T; Niida A; Inoue H; Imoto S; Kawano S; Yamaguchi R; Toh H; Iinuma H; Ishimaru S; Ishii H; Suzuki S; Tokudome S; Watanabe M; Tanaka J; Kudo SE; Mochizuki H; Kusunoki M; Yamada K; Shimada Y; Moriya Y; Miyano S; Sugihara K; Mori M
Ann Surg Oncol; 2013 Apr; 20(4):1395-402. PubMed ID: 22976378
[TBL] [Abstract][Full Text] [Related]
48. Gene variants of TCF7L2 are histopathologically important in colorectal cancers but do not have direct association with MYC expression.
Ozkan Kucuk NE; Horozoglu C; Timirci Kahraman O; Arikan S; Farooqi AA; Turan S; Korkmaz G; Kelten Talu EC; Sabitaliyevich UY; Yaylim I
Cell Mol Biol (Noisy-le-grand); 2019 Dec; 65(8):1-6. PubMed ID: 32133972
[TBL] [Abstract][Full Text] [Related]
49. Analysis of specific transcriptional regulators as early predictors of independent prognostic relevance in resected colorectal cancer.
Maurer GD; Leupold JH; Schewe DM; Biller T; Kates RE; Hornung HM; Lau-Werner U; Post S; Allgayer H
Clin Cancer Res; 2007 Feb; 13(4):1123-32. PubMed ID: 17317820
[TBL] [Abstract][Full Text] [Related]
50. Matrix metalloproteinase (MMP) -2, -7 and -9 promoter polymorphisms in colorectal cancer in ethnic Kashmiri population - A case-control study and a mini review.
Banday MZ; Sameer AS; Mir AH; Mokhdomi TA; Chowdri NA; Haq E
Gene; 2016 Sep; 589(1):81-89. PubMed ID: 27222481
[TBL] [Abstract][Full Text] [Related]
51. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
[TBL] [Abstract][Full Text] [Related]
52. [Abnormal expression of APRIL in colorectal cancer cells promotes tumor growth and metastasis].
Wang GH; Lu MH; Wang JC; Wang F; Ding WF; Wang YG; Ju SQ; Wang HM
Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):249-55. PubMed ID: 23985251
[TBL] [Abstract][Full Text] [Related]
53. miR-375 inhibits the invasion and metastasis of colorectal cancer via targeting SP1 and regulating EMT-associated genes.
Cui F; Wang S; Lao I; Zhou C; Kong H; Bayaxi N; Li J; Chen Q; Zhu T; Zhu H
Oncol Rep; 2016 Jul; 36(1):487-93. PubMed ID: 27222350
[TBL] [Abstract][Full Text] [Related]
54. A Germline Mutation in the BRCA1 3’UTR Variant Predicts Susceptibility to Breast Cancer in a Saudi Arabian Population.
Mir R; Javid J; Al Balawi IA; Alkharsah KR; Hadi MA; Rahman MA; Hamoud E; Al Alawi Y; Al Zahrani ABM; Abu-Duhier FM
Asian Pac J Cancer Prev; 2018 Mar; 19(3):859-866. PubMed ID: 29582646
[TBL] [Abstract][Full Text] [Related]
55. An NKX3.1 binding site polymorphism in the l-plastin promoter leads to differential gene expression in human prostate cancer.
Chen C; Cai Q; He W; Li Z; Zhou F; Liu Z; Zhong G; Chen X; Zhao Y; Dong W; Huang J; Zheng J; Lin T
Int J Cancer; 2016 Jan; 138(1):74-86. PubMed ID: 26148677
[TBL] [Abstract][Full Text] [Related]
56. Sp1 regulates osteopontin expression in SW480 human colon adenocarcinoma cells.
Takami Y; Russell MB; Gao C; Mi Z; Guo H; Mantyh CR; Kuo PC
Surgery; 2007 Aug; 142(2):163-9. PubMed ID: 17689681
[TBL] [Abstract][Full Text] [Related]
57. TRAIL induces apoptosis but not necroptosis in colorectal and pancreatic cancer cells preferentially via the TRAIL-R2/DR5 receptor.
Nahacka Z; Svadlenka J; Peterka M; Ksandrova M; Benesova S; Neuzil J; Andera L
Biochim Biophys Acta Mol Cell Res; 2018 Mar; 1865(3):522-531. PubMed ID: 29278689
[TBL] [Abstract][Full Text] [Related]
58. rs3918242 variant genotype frequency and increased TIMP-2 and MMP-9 expression are positively correlated with cancer invasion in urinary bladder cancer.
Pençe S; Özbek E; Ozan Tiryakioğlu N; Ersoy Tunali N; Pençe HH; Tunali H
Cell Mol Biol (Noisy-le-grand); 2017 Sep; 63(9):46-52. PubMed ID: 28980922
[TBL] [Abstract][Full Text] [Related]
59. Functional implication of TRAIL -716 C/T promoter polymorphism on its in vitro and in vivo expression and the susceptibility to sporadic breast tumor.
Pal R; Gochhait S; Chattopadhyay S; Gupta P; Prakash N; Agarwal G; Chaturvedi A; Husain N; Husain SA; Bamezai RN
Breast Cancer Res Treat; 2011 Apr; 126(2):333-43. PubMed ID: 20443055
[TBL] [Abstract][Full Text] [Related]
60. Repression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but not its receptors during oral cancer progression.
Vigneswaran N; Baucum DC; Wu J; Lou Y; Bouquot J; Muller S; Zacharias W
BMC Cancer; 2007 Jun; 7():108. PubMed ID: 17592646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]